MetLife Inc., US59156R1086

JPMorgan raises target to USD 110 for MetLife stock

Published on 10/16/2026 at 09:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
JPMorgan lifted its target from USD 108 to USD 110 on October 15, 2026. MetLife stock trades at EUR 89.33 at Lang & Schwarz.

Analyst target and reporting dates

  • JPMorgan raised its MetLife target from USD 108 to USD 110 on October 15, 2026.
  • MetLife reported adjusted earnings of USD 1.6 billion for the second quarter of 2026.
  • MetLife stock trades at EUR 89.33 at 9:17 a.m. CEST at Lang & Schwarz on October 16, 2026.
Architektur-Render eines modernen Glasturms mit Platzanlage, konzeptionell zugehörig zu MetLife Inc., ISIN US59156R1086, Illustration mit AI erstellt.

MetLife Inc. (ISIN US59156R1086) stock was trading at EUR 89.33 at Lang & Schwarz on October 16, 2026 at 9:17 a.m. CEST. The latest analyst catalyst came from JPMorgan, which raised its MetLife target from USD 108 to USD 110 on October 15, 2026, while retaining an Overweight rating, according to Markets Insider.

JPMorgan sees longer-term value

JPMorgan made the adjustment as part of a third-quarter earnings preview. The bank cited near-term headwinds but also identified longer-term reasons for a more constructive view, according to the same October 15 report.

The move followed several target changes in October. MarketBeat reported that DOWLING & PARTN raised its fiscal-year 2026 earnings-per-share forecast to USD 10.30 from USD 10.10 on October 13, 2026.

What does the earnings base show?

MetLife's second-quarter 2026 adjusted earnings reached USD 1.6 billion, up 15 percent from the prior-year period, while adjusted earnings per share rose 20 percent to USD 2.43, according to ScanX. Group Benefits adjusted earnings increased 25 percent, giving the latest quarterly report a clear operating counterweight to the short-term headwinds cited by JPMorgan.

Three analyst milestones

On October 5, 2026, TD Cowen raised its MetLife target to USD 110 from USD 105, as reported by Markets Insider. On October 13, 2026, DOWLING & PARTN lifted its fiscal-year 2026 forecast to USD 10.30 from USD 10.10, according to MarketBeat. On October 15, 2026, JPMorgan raised its target to USD 110 from USD 108, according to Markets Insider.

Upcoming dates carry the next test

MetLife's next substantiated dates are November 3, 2026, for the ex-dividend date, and November 4, 2026, for third-quarter results, according to MarketBeat and Gekko. The dividend is USD 0.5925 per share, with an annualized payout of USD 2.37.

Stock price and company scale

MetLife was trading at EUR 89.33 at Lang & Schwarz on October 16, 2026 at 9:17 a.m. CEST. The company had a market capitalization of USD 63.7 billion as of October 15, 2026, while its primary listing is on the NYSE under ticker MET.

The further course of trading is shown by the continuously updated real-time quote of MetLife stock.

MetLife stock at a glance

  • Company: MetLife, Inc.
  • ISIN: US59156R1086
  • Ticker: MET
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 16, 2026, 9:17 a.m. CEST): EUR 89.33
  • Market capitalization: USD 63.7 billion (as of October 15, 2026)
  • Sector / Industry: Financial Services / Insurance - Life
  • Index membership: S&P 500

Market context: Market report S&P 500.

More news and analyses on MetLife stock

Disclaimer...
en | US59156R1086 | METLIFE INC. | boerse | 70337278 | bgmi